Curaleaf Holdings, Inc.: Form 40-F for the period ended Dec 31, 2024
Filed with the SEC on Mar 4, 2025 and accepted by EDGAR at Mar 3, 2025, 20:04 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | $1.34bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2024-01-01 to 2024-12-31 | $703.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2024-01-01 to 2024-12-31 | $639.2m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2024-01-01 to 2024-12-31 | $421.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2024-01-01 to 2024-12-31 | $20.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2024-01-01 to 2024-12-31 | $98.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-01-01 to 2024-12-31 | −$215.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | −$0.32 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | −$0.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-01-01 to 2024-12-31 | 740,825,099 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | $162.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2024-01-01 to 2024-12-31 | $93.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2024-12-31 | $429.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $2.95bn | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $387.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-12-31 | $1.96bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-12-31 | $466.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-12-31 | $101.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-12-31 | $861.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001756770-25-000008. Last ingested by Listed: Nov 5, 2026, 13:45 ET. Listed shows no prices and gives no investment advice.